SP Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $49.2M | Sell |
226,049
-2,453
| -1% | -$544K | 4.34% | 5 |
|
|
2025
Q4 | $52.2M | Buy |
228,502
+1,498
| +0.7% | +$341K | 4.13% | 5 |
|
|
2025
Q3 | $52.6M | Buy |
227,004
+1,067
| +0.5% | +$217K | 4.17% | 5 |
|
|
2025
Q2 | $41.9M | Buy |
225,937
+588
| +0.3% | +$109K | 3.46% | 6 |
|
|
2025
Q1 | $47.2M | Buy |
225,349
+14
| +0% | +$2.72K | 4.16% | 4 |
|
|
2024
Q4 | $40M | Sell |
225,335
-640
| -0.3% | -$118K | 3.36% | 7 |
|
|
2024
Q3 | $44.6M | Buy |
225,975
+1,195
| +0.5% | +$223K | 3.71% | 4 |
|
|
2024
Q2 | $38.6M | Sell |
224,780
-3,001
| -1% | -$497K | 3.51% | 5 |
|
|
2024
Q1 | $41.5M | Sell |
227,781
-1,782
| -0.8% | -$307K | 3.86% | 3 |
|
|
2023
Q4 | $35.6M | Buy |
229,563
+6,658
| +3% | +$971K | 3.65% | 4 |
|
|
2023
Q3 | $33.2M | Buy |
222,905
+21,739
| +11% | +$3.19M | 3.73% | 3 |
|
|
2023
Q2 | $27.1M | Buy |
201,166
+13,334
| +7% | +$1.96M | 3.02% | 8 |
|
|
2023
Q1 | $29.9M | Buy |
187,832
+443
| +0.2% | +$67.7K | 3.67% | 5 |
|
|
2022
Q4 | $30.3M | Buy |
187,389
+486
| +0.3% | +$74.5K | 4.05% | 4 |
|
|
2022
Q3 | $25.1M | Buy |
186,903
+13,313
| +8% | +$1.91M | 3.43% | 6 |
|
|
2022
Q2 | $26.6M | Buy |
173,590
+242
| +0.1% | +$37K | 3.39% | 6 |
|
|
2022
Q1 | $28.1M | Buy |
173,348
+1,794
| +1% | +$261K | 3.02% | 6 |
|
|
2021
Q4 | $23.5M | Buy |
171,554
+1,874
| +1% | +$221K | 2.35% | 7 |
|
|
2021
Q3 | $18.4M | Buy |
169,680
+37,825
| +29% | +$4.32M | 1.92% | 9 |
|
|
2021
Q2 | $15.6M | Buy |
131,855
+3,035
| +2% | +$342K | 1.71% | 13 |
|
|
2021
Q1 | $14.8M | Buy |
128,820
+9,290
| +8% | +$994K | 1.84% | 11 |
|
|
2020
Q4 | $13M | Buy |
119,530
+1,316
| +1% | +$126K | 1.79% | 12 |
|
|
2020
Q3 | $11.1M | Buy |
118,214
+27,011
| +30% | +$2.54M | 1.7% | 13 |
|
|
2020
Q2 | $8.95M | Buy |
91,203
+1,106
| +1% | +$97.4K | 1.88% | 13 |
|
|
2020
Q1 | $6.86M | Buy |
90,097
+4,747
| +6% | +$404K | 1.87% | 13 |
|
|
2019
Q4 | $7.56M | Sell |
85,350
-312
| -0.4% | -$25.9K | 1.73% | 14 |
|
|
2019
Q3 | $6.49M | Buy |
85,662
+1,645
| +2% | +$113K | 1.67% | 17 |
|
|
2019
Q2 | $6.11M | Buy |
84,017
+1,400
| +2% | +$110K | 1.56% | 17 |
|
|
2019
Q1 | $6.66M | Sell |
82,617
-860
| -1% | -$70.4K | 1.82% | 15 |
|
|
2018
Q4 | $7.7M | Buy |
83,477
+5,141
| +7% | +$452K | 2.35% | 11 |
|
|
2018
Q3 | $7.4M | Sell |
78,336
-225
| -0.3% | -$21.3K | 2.1% | 11 |
|
|
2018
Q2 | $7.4M | Buy |
+78,561
| New | +$7.67M | 2.02% | 9 |
|
Other funds holding ABBV
VCM
VPM
SP Asset Management's ABBV Position: Q1 2026 in Review
SP Asset Management reduced its AbbVie (ABBV) stake by 1.1% in Q1 2026, selling an estimated $544K and leaving 226,049 shares worth $49.2M. The position accounts for 4.34% of the portfolio, ranked #5.
SP Asset Management first reported a position in ABBV in Q2 2018 and has held it in 32 quarters since. The position peaked at $52.6M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- SP Asset Management held 226,049 shares of AbbVie worth $49.2M as of Q1 2026.
- SP Asset Management sold 2,453 AbbVie shares in Q1 2026, an estimated $544K.
- AbbVie made up 4.34% of SP Asset Management's portfolio in Q1 2026, its #5 holding.
- SP Asset Management first reported a position in AbbVie in Q2 2018 and has held it in 32 quarters since.
- SP Asset Management's AbbVie position peaked at $52.6M in Q3 2025.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on SP Asset Management's 13F filing for Q1 2026, filed 7 May 2026.